FRMPD1: A Potential Drug Target and Biomarker (G22844)

Target Name: FRMPD1

NCBI ID: G22844

FRMPD1

FRMPD1: A Potential Drug Target and Biomarker

The FERM domain is a protein family that is characterized by the presence of a unique nucleotide-binding oligomerization domain (NBO domain) and a repetitive motif. FERM domain-containing proteins (FRPDs) are a diverse group of proteins that are involved in various cellular processes, including cell signaling, DNA replication, and metabolism. One of the most well-studied FRMDs is FRMPD1, which is a protein that is expressed in various tissues and cells and is known to play a role in the regulation of gene expression. In In this article, we will explore the FRMPD1 protein, its potential drug target status, and its potential as a biomarker for various diseases.

Structure and Function

The FRMPD1 protein is a 21-kDa protein that is composed of 215 amino acid residues. It has a unique NBO domain that is characterized by the presence of a nucleotide-binding oligomerization domain (NBO), a conserved core domain, and a variable region . The NBO domain is the protein's most well-conserved region and is involved in the formation of a nucleotide-binding oligomerization complex (NBO complex), which is responsible for binding to specific nucleotides in the target gene.

FRMPD1 is a transcriptional regulator that is involved in the regulation of gene expression. It has been shown to interact with various DNA-binding proteins, including the DNA-binding protein p21 (E2F1), which is a key regulator of cell growth and cycle. p21 is a transcription factor that is involved in the regulation of cell growth, apoptosis, and DNA replication. By interacting with p21, FRMPD1 can modulate the activity of p21 and thereby regulate gene expression.

FRMPD1 has also been shown to interact with other proteins that are involved in the regulation of gene expression, including the transcription factor TF-1, which is responsible for the regulation of cell growth and differentiation. TF-1 is a transcription factor that is involved in the regulation of gene expression by binding to specific DNA-binding proteins.

Potential Drug Target

FRMPD1 is a potential drug target because of its involvement in the regulation of gene expression. Drugs that target FRMPD1 have the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the reasons why FRMPD1 is a potential drug target is because it is involved in the regulation of cell growth and cycle. Drugs that target FRMPD1 have the potential to inhibit its activity and thereby inhibit cell growth and cycle, leading to the potential for therapeutic intervention. For example, inhibitors of the FRMPD1-p21 interaction have been shown to have therapeutic potential in the treatment of cancer.

Another reason why FRMPD1 is a potential drug target is because it is involved in the regulation of apoptosis. FRMPD1 has been shown to be involved in the regulation of apoptosis, which is a natural process that is responsible for the elimination of damaged or dysfunctional cells. Drugs that target FRMPD1 have the potential to inhibit its activity and thereby promote apoptosis, which could be useful in the treatment of certain diseases.

Potential Biomarkers

FRMPD1 is also a potential biomarker for various diseases. Its involvement in the regulation of gene expression makes it a useful marker for the diagnosis and prognosis of various diseases. For example, FRMPD1 has been shown to be involved in the regulation of cancer cell proliferation, which makes it a potential biomarker for the

Protein Name: FERM And PDZ Domain Containing 1

Functions: Stabilizes membrane-bound GPSM1, and thereby promotes its interaction with GNAI1

The "FRMPD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRMPD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets